all news

Our partners are building great companies. We love to share their stories.

Wed, 29 Nov 2023 KSQ Therapeutics

3. KSQ Therapeutics Announces FDA Clearance of IND Application for Engineered Tumor Infiltrating Lymphocyte Therapy

Wed, 29 Nov 2023 Neumora Therapeutics, Inc.

2. Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

Tue, 28 Nov 2023

1. Tectonic Therapeutic Announces Start of First Clinical Program for GPCR-Targeted Biologic

Tue, 14 Nov 2023

TRexBio Announces Development Candidate for the Treatment of Inflammatory Diseases

Fri, 10 Nov 2023 Kallyope

Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases

Tue, 7 Nov 2023 GlobeNewswire News Room

Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

Thu, 2 Nov 2023 MedCity News

BeMe Health Partners With 2 Health Plans To Support Teen Mental Health

Wed, 1 Nov 2023

Siemens Healthineers Selects Baxter Planning To Transform its Service Supply Chain

Tue, 31 Oct 2023 Yahoo! Finance

Engine Biosciences Secures $27 Million Series A Extension to Advance Development of Precision Oncology Medicines and Novel Biomarkers for Pa

Mon, 30 Oct 2023 Volastra

Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated

Thu, 26 Oct 2023 Newswire

Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy

Thu, 26 Oct 2023 BioSpace

Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological

Wed, 25 Oct 2023 Associated Press

Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies

Tue, 24 Oct 2023 Yahoo! Finance

ByHeart Becomes First and Only US-Made Infant Formula to Achieve Clean Label

Tue, 24 Oct 2023

Ankyra Therapeutics Receives FDA IND and Health Canada CTA Approval to Advance First-In-Class Selective Anchored Immunotherapy Agent, ANK-10

Thu, 19 Oct 2023 FierceBiotech

Hummingbird’s HER3-targeted ADC entices Endeavor to sign $430M licensing deal

Thu, 19 Oct 2023 India - PRNewswire

FOLX Health Now In-Network with Regional and National Health Plans, Ensuring LGBTQIA+ Folks Have Improved Access to Life-Saving Health Care

Thu, 5 Oct 2023 India - PRNewswire

65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Si

Mon, 2 Oct 2023

OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand Real-World Evidence in Respiratory and ENT

Mon, 2 Oct 2023

Capstan Therapeutics Co-Founder Drew Weissman, M.D., Ph.D., Awarded Nobel Prize in Physiology or Medicine for Enabling Rapid Development of

Wed, 27 Sep 2023 Business Wire

Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes

Wed, 27 Sep 2023 India - PRNewswire

Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field

Thu, 21 Sep 2023 BioSpace

Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel

Thu, 21 Sep 2023

Endpoints News Announces the 2023 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups

Thu, 21 Sep 2023 PR Newswire

Brella™ 3-Minute SweatControl Patch Wins Prestigious Allure 2023 Best of Beauty Breakthrough Award

Tue, 19 Sep 2023 PR Newswire

Baxter Planning's predictive Service Supply Chain platform chosen by Roche Diagnostics Corporation for Service Supply Chain Optimization

Sat, 16 Sep 2023 GlobeNewswire

Neumora Therapeutics Announces Pricing of Initial Public Offering

Wed, 13 Sep 2023 Behavioral Health Business

Gen Z Women’s Health Provider Caraway Acquires Digital Group Therapy Platform Sesh

Wed, 13 Sep 2023 Dewpoint Therapeutics

Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targetin

Thu, 7 Sep 2023 HIT Consultant

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience